Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
blood cancer
Pharma
Takeda wins FDA nod for first-in-class blood cancer drug Mimrylo
One of three key launches for Takeda's next phase of growth, Mimrylo is the first drug for polycythemia vera that mimics hepcidin.
Angus Liu
Aug 28, 2026 10:04pm
Roche tops cancer reputation rankings as AstraZeneca climbs back
Jul 2, 2026 6:00am
AbbVie, Genmab's Epkinly redeems itself in DLBCL
Jun 30, 2026 9:50am
BeOne’s Brukinsa hits goal in lymphoma confirmatory trial
Jun 30, 2026 6:00am
BeOne boosts support for Blood Cancer United with $5M commitment
Jun 26, 2026 3:57am
Lilly oncology chief ‘blown away’ by new Jaypirca CLL data
Jun 15, 2026 8:25am
